B
Workshops and Roundtable: Agendas and Participants
INSTITUTE OF MEDICINE
NATIONAL ACADEMY OF SCIENCES
Committee on Community-Based Drug Treatment
Roundtable on Community-Based Drug Treatment:
The Need for Partnership Among Providers, Policymakers, and Researchers
Tuesday, July 29, 1997
Lecture Room, National Academy of Sciences
2101 Constitution Avenue, N.W., Washington, D.C.
WORKSHOP AGENDA
10:00 a.m |
Welcome and Introductions—Overview of Objectives for the Day and Review of Open Meetings Policy* Merwyn R. Greenlick, Committee Chair |
10:25 |
Provider Panelists—Robert Fullilove, Panel Host Arthur Schut,* President, Iowa Substance Abuse Program Director's Association Anne Tafe,* Executive Director, Massachusetts Drug Abuse Association Robert Kahn,* President, California Organization of Methadone Providers Robert G. Newman,* President and CEO, Beth Israel Medical Center Selbert Wood,* President and CEO, STEP ONE, Inc. Gaurdia Banister, Director of Behavioral Health Services, Seton House Beny J. Primm, Executive Director, Addiction Research and Treatment Corporation Mark Publickler, Chief of Addiction Medicine, Kaiser Permanente Mid-Atlantic Region Discussion: Question and Answer |
11:35 |
Policy Panelists—Steven Mirin, Panel Host Marsha Lillie-Blanton, Associate Director, U.S. General Accounting Office Rosalind Brannigan, Vice President, Drug Strategies June Osborn, President, Josiah Macy Jr. Foundation Hernando Posada Assistant Director, Ohio Department of Alcohol and Drug Addiction Services Richard Suchinsky, Addictive Disorders, Department of Veterans Affairs Discussion: Question and Answer |
12:45 p.m. |
LUNCH—Provided for panelists and registered observers outside the Lecture Room |
1:30 |
Research Panelists—James Sorenson, Panel Host Lisa Borg, Rockefeller University Alec Cristoff, Alexandria, VA Jeffrey Hoffman, President and CEO, Danya International, Inc. |
|
David Nurco, Social Research Center, University of Maryland at Baltimore Harold Shinitzky, Department of Pediatrics, Johns Hopkins University School of Medicine Maxine Stitzer, Principal Investigator, Behavioral Biology Research Center, Johns Hopkins University School of Medicine George Woody, Department of Psychiatry, University of Pennsylvania Discussion: Question and Answer |
2:40 |
General Discussion |
3:30 |
Summary Recommendations and Wrap-up |
4:00-5:00 |
RECEPTION for Roundtable participants in the Rotunda |
LIST OF TOPICS TO BE ADDRESSED BY PARTICIPANTS
PARTICIPANT LIST
Gaurdia E. Banister
Director of Behavioral Health Services
Seton House
Washington, DC
Lisa Borg
Laboratory of the Biology of Addictive Diseases
Rockefeller University
New York, NY
Joseph V. Brady
Professor of Behavioral Biology
The Johns Hopkins University School of Medicine
Baltimore, MD
Rosalind Brannigan
Vice President
Drug Strategies
Washington, DC
Mady Chalk
Director, Managed Care Initiatives
Center for Substance Abuse Treatment
Rockville, MD
Alec Christoff
Alexandria, VA
Dorynne Czechowicz
Division of Clinical and Services Research
National Institute on Drug Abuse
Rockville, MD
Deborah Haller
Associate Chair
Division of Substance Abuse Medicine
Medical College of Virginia
Virginia Commonwealth University
Richmond, VA
Vincent G. Hodge
Employee Assistance Consultant
COPE, Inc.
Washington, DC
Jeffrey A. Hoffman
President and CEO
Danya International, Inc.
Silver Spring, MD
Robin Huffman
Regional Director of Business Development/Charter Behavioral
North Carolina Association for Behavioral Health Care
Greensboro, NC
Robert B. Kahn
President, California Organization of Methadone Providers
San Diego, CA
Andrea Kamargo
Health Services Quality and Public Health Issues
U.S. General Accounting Office
Washington, DC
Linda Kaplan
Executive Director
The National Association of Alcoholism and Drug Abuse Counselors
Arlington, VA
Marsha Lillie-Blanton
Associate Director
Health Services Quality and Public Health Issues
U.S. General Accounting Office
Washington, DC
James O. McClyde
Assistant Director
Health Services Quality and Public Health Issues
U.S. General Accounting Office
Washington, DC
Robert G. Newman
President and CEO
Beth Israel Medical Center
New York, NY
David N. Nurco
Research Professor
Department of Psychiatry
University of Maryland at Baltimore
Baltimore, MD
June Osborn
President
Josiah Macy Jr. Foundation
New York, NY
Nina Peyser
Executive Director
Grants Management and Research Support
Beth Israel Medical Center
New York, NY
Harold Alan Pincus
Deputy Medical Director and
Director, Office of Research American Psychiatric Association
Washington, DC
Hernando J. Posada
Assistant Director
Ohio Department of Alcohol and Drug Addiction Services
Columbus, OH
Beny J. Primm
Executive Director
Addiction Research and Treatment Corporation
Brooklyn, NY
Mark Publicker
Chief of Addiction Medicine
Kaiser Permanente Mid-Atlantic Region
Merrifield, VA
Gwen Rubinstein
Deputy Director of National Policy
Legal Action Center
Washington, DC
Arthur Schut
President, Iowa Substance Abuse Program Directors' Association
c/o Mid-Eastern Council on Chemical Abuse
Iowa City, IA
Harold Shinitzky
Psychology Instructor
Department of Pediatrics
Johns Hopkins University
School of Medicine
Baltimore, MD
Maxine L. Stitzer
Professor of Psychiatry and Behavioral Sciences
Johns Hopkins University
School of Medicine
Baltimore, MD
Richard T. Suchinsky
Associate Chief for Addictive Disorders
Department of Veterans Affairs
Washington, DC
Anne Tafe
Executive Director
Massachusetts Alcoholism and Drug Abuse Association
Boston, MA
Selbert M. Wood, Jr.
President and CEO
STEP ONE, Inc.
Winston-Salem, NC
INSTITUTE OF MEDICINE
NATIONAL ACADEMY OF SCIENCES
Committee on Committee-Based Drug Treatment
Workshop on Community-Based Drug Treatment:
The Need for Partnership Among Providers, Policymakers, and Researchers
September 8, 1997
Scholes Hall—Roberts Room
University of New Mexico Campus
Albuquerque, NM
WORKSHOP AGENDA
10:30 a.m. |
Welcome and Introductions Merwyn R. Greenlick, Committee Chair Philip A. May, Director, CASAA |
|
Review of IOM Open Meeting Policy Overview of Objectives for the Day |
11:00 |
Overview of the community-based drug abuse treatment system in New Mexico, including diverse cultures and special populations (e.g., community corrections, adolescents, pregnant women) |
12:30 p.m. |
Break to pick up box lunches |
12:45 |
Examples of research carried out in community-based programs with providers as partners from the beginning |
1:30 |
Examples of successes and failures in dissemination of research findings and utilization of relevant clinical experience in the design of research |
2:15 |
Perspectives of community providers on the pros and cons of participating in research. What research is needed and why? |
3:00 |
Wrap-up and Summary |
3:30 |
Adjourn workshop |
PARTICIPANT LIST
Patrick Abbott
Center on Alcoholism, Substance Abuse and Addiction
Albuquerque, NM
Lynn Brady
Behavioral Health Services Division
Department of Health
Santa Fe, NM
Robert Fiorentine
Drug Abuse Research Center
University of California at Los Angeles
Los Angeles, CA
Jan Gossage
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
Valerie L. Graber
Student Support Services
Albuquerque, NM
Linda Grant
Washington Association of Alcoholism and Addictions Programs
Kirkland, WA
Brian Greenberg
Walden House
San Francisco, CA
James Hall
Sante Fe County District Court
Sante Fe, NM
Constance Horgan
Institute for Health Policy
Brandeis University
Waltham, MA
Arnold Kaluzny
University of North Carolina
School of Public Health
Cecil G. Sheps Center
Chapel Hill, NC
Michael W. Kirby
Arapahoe House, Inc.
Thorton, CO
Patricia Knox
The Center for Alcohol and Drug Treatment
Wenatchee, WA
Walter Lang
New Mexico State Probation and Parole
Albuquerque, NM
Francesca G. Lanier
Grant Management and Accountability
Albuquerque Public Schools
Albuquerque, NM
Carol Leonard
The Navajo Nation
Dine'Center for Substance Abuse Treatment
Window Rock, AZ
Chilo Madrid
Aliviane, Inc.
El Paso, TX
Philip A. May
University of New Mexico
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
Robert Meyers
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
Rick Miera
Bernalillo County Juvenile Detention Center and New Mexico State Legislature
Albuquerque, NM
Joseph "Bo" Miller
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
Josi Noyes
EAP Public Service Co. of New Mexico
(Retired)
Sandia Park, NM
Carole Otero
Albuquerque Metropolitan Central Intake
Albuquerque, NM
Michael M. Passi
Family and Community Services Department
Albuquerque, NM
Robert Phillips
Eastern New Mexico University-Roswell
Roswell, NM
Fernando Rodriquez
Aliviane, Inc.
El Paso, TX
Everett Rogers
Department of Communication and Journalism
University of New Mexico
Albuquerque, NM
Mary E. Steil
City of Albuquerque, Family and Community Services Department
Albuquerque, NM
Scott Wallace
San Juan County DWI Treatment Facility
Farmington, NM
Verner Westerberg
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
W. Gill Woodall
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
Carolina E. Yahne
Center on Alcoholism, Substance Abuse and Addictions
Albuquerque, NM
INSTITUTE OF MEDICINE
NATIONAL ACADEMY OF SCIENCES
Committee on Committee-Based Drug Treatment
Roundtable Discussion with Local Providers
October 23, 1997
Seton House at Providence Hospital
Washington, DC
PARTICIPANT LIST
Darryl Colbert
Program Administrator
Substance Abuse Network
Catholic Charities Washington, DC
Diane Lewis
Consultant
Marshall Heights Community Development Organization
Washington, DC
Arthur Melvin
Clinic Manager
Umoja Treatment Center
Washington, DC
Betty Palmer
Nurse Manager
Seton House at Providence Hospital
Washington, DC
Gale Saler
Executive Deputy
Director Second Genesis
Bethesda, MD
Steve Wright
Center Manager
Addiction, Prevention, and Recovery Administration
Washington, DC
Ronald D. Wynne
Director
Washington Assessment and Therapy Services
Washington, DC